High-throughput PCR testing system for SARS-CoV-2 detection under FDA/EUA

As the need for SARS-CoV-2 testing continues to grow for both diagnostic and screening applications, many organizations are looking to expand or create testing capacity. For existing diagnostic labs, limited supplies of instruments, reagents, and laboratory technologists make getting high volumes of testing done in a timely manner challenging.


With the high-throughput (HTP) RT-PCR testing system for SARS-CoV-2, EUA request submitted, testing labs can leverage Biosearch Technologies’ expertise in automated sample preparation and RT-PCR workflows in a ready-to-deploy sample-to-answer solution. This system delivers a capacity of 4,500-35,000 tests per day.



Biosearch Technologies’ SARS-CoV-2 testing workflow is an optimized hardware, reagents, consumables, and software bundle that includes:

A dedicated customer service representative who ensures that your supply, hardware, and service needs are anticipated and met. Testing capacity can be expanded from hundreds or thousands of samples to as many as 35,000 samples per day with minimal need for additional staff, instrumentation, or lab space.



Why choose Biosearch Technologies' SARS-CoV-2 testing system?

- Expand capacity by running 4,500-35,000 tests per day.